SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?


To: TATRADER who wrote (2684)8/24/1998 11:10:00 PM
From: Dan Lisman  Respond to of 59879
 
Mark, I read this as a simple stock swap. I took the dollar references to be examples of stock price for that point in time only.
"Under the terms of the agreement, Arakis shareholders will receive one Talisman share for every ten Arakis shares."
"Talisman will issue 8.92 million common shares based on 89.2 million Arakis shares outstanding."

I don't see any actual exchange of cash.
Dan



To: TATRADER who wrote (2684)8/25/1998 8:51:00 AM
From: Christopher  Read Replies (2) | Respond to of 59879
 
TATRADER, Question about Dial Data.
Are you happy with Dial Data? Do you have much trouble downloading daily data? Do you have problem logging on to Dial Data to
download or anything else? Will appreciate your input.

Good luck trading.

Christopher



To: TATRADER who wrote (2684)8/25/1998 10:11:00 AM
From: JJMM  Respond to of 59879
 
NLAB news out today regarding positive results in human tests of their
cancer treatment compound in over 200 patients with a variety of
cancers. Chart looks interesting.

NuOncology Labs (NLAB)

today's news

biz.yahoo.com

Good Luck



To: TATRADER who wrote (2684)8/25/1998 10:50:00 AM
From: Rashid Garuba  Respond to of 59879
 
Mark,

Out of AKSEF. My last trade till next week.... Rashid